Prellis Biologics, Inc
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Prellis Biologics, Inc chose not to state its revenue in its newest notice of a funding round (Jul 2022).
SEC Form D · Jul 2022
The industry group it chose in its notices: Other Technology.
SEC Form D · Jul 2022
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Prellis Biologics, Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Melanie Matheu | Executive officer | Jul 2022 |
| Noelle Mullin | Executive officer | Jul 2017 |
| Alex Morgan | Director | Jul 2022 |
| Lei Meng | Director | Jul 2022 |
| Melanie Matheu | Director | Jul 2022 |
| Michael Marks | Director | Jul 2022 |
| Sean O'Sullivan | Director | Jul 2022 |
| Shaun Holt | Director | Jul 2022 |
| Arvind Gupta | Director | Jul 2021 |
| Rohit Sharma | Director | Mar 2019 |
| Noelle Mullin | Director | Jul 2017 |